Literature DB >> 11549670

Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution.

A P Goldstone1, E L Thomas, A E Brynes, J D Bell, G Frost, N Saeed, J V Hajnal, J K Howard, A Holland, S R Bloom.   

Abstract

Visceral obesity is detrimental to health, but the mechanisms controlling body fat distribution are not fully understood. In premenopausal adult females (30 nonobese, 14 obese [body mass index >30 kg/m(2)]), variance in fasting insulin, glucose, insulin/glucose ratio, C-peptide/insulin ratio, triglycerides, and high-density lipoprotein/low-density lipoprotein-cholesterol ratio, were independently influenced by visceral but not total sc or abdominal sc adipose tissue, as measured by whole-body magnetic resonance imaging. Adult females with Prader-Willi syndrome (n = 13) had significantly reduced visceral adiposity, compared with obese controls (visceral/total sc adipose tissue ratio: 0.067 +/- 0.017 vs. 0.108 +/- 0.021), independent of their total adiposity (P < 0.001), or use of exogenous sex steroids. This is in contrast to that expected by their physical inactivity, hypogonadism, adult GH deficiency, and psychiatric problems. Females with Prader-Willi syndrome not receiving sex steroids (n = 8) had significantly reduced fasting insulin, insulin/glucose ratio, and triglycerides and increased C-peptide/insulin ratio, compared with obese controls, adjusting for total (P < 0.05) but not visceral adiposity (P = 0.3-0.6), supporting their association. The cause of the reduced visceral adiposity in Prader-Willi syndrome may reflect novel hormonal, hypothalamic, and/or genetic influences on body fat distribution.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549670     DOI: 10.1210/jcem.86.9.7814

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment.

Authors:  T Cadoudal; M Buléon; C Sengenès; G Diene; F Desneulin; C Molinas; S Eddiry; F Conte-Auriol; D Daviaud; P G P Martin; A Bouloumié; J-P Salles; M Tauber; P Valet
Journal:  Int J Obes (Lond)       Date:  2014-01-10       Impact factor: 5.095

2.  Does segmental body composition differ in women with Prader-Willi syndrome compared to women with essential obesity?

Authors:  G Bedogni; G Grugni; G Tringali; N Marazzi; A Sartorio
Journal:  J Endocrinol Invest       Date:  2015-04-04       Impact factor: 4.256

Review 3.  Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.

Authors:  Antonino Crinò; Graziano Grugni
Journal:  Curr Diab Rep       Date:  2020-02-06       Impact factor: 4.810

Review 4.  Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.

Authors:  Rasmus Sode-Carlsen; Stense Farholt; Kai Fr Rabben; Jens Bollerslev; Thomas Schreiner; Anne Grethe Jurik; Jens Sandahl Christiansen; Charlotte Höybye
Journal:  Endocrine       Date:  2011-11-12       Impact factor: 3.633

5.  Changes in levels of peripheral hormones controlling appetite are inconsistent with hyperphagia in leptin-deficient subjects.

Authors:  Sadia Saeed; Paul R Bech; Tayyaba Hafeez; Rabail Alam; Mario Falchi; Mohammad A Ghatei; Stephen R Bloom; Muhammad Arslan; Philippe Froguel
Journal:  Endocrine       Date:  2013-07-04       Impact factor: 3.633

6.  Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone.

Authors:  Krystal A Irizarry; James Bain; Merlin G Butler; Olga Ilkayeva; Michael Muehlbauer; Andrea M Haqq; Michael Freemark
Journal:  Clin Endocrinol (Oxf)       Date:  2015-04-01       Impact factor: 3.478

Review 7.  Prader-Willi, Angelman, and 15q11-q13 Duplication Syndromes.

Authors:  Louisa Kalsner; Stormy J Chamberlain
Journal:  Pediatr Clin North Am       Date:  2015-04-22       Impact factor: 3.278

8.  The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index.

Authors:  Andrea M Haqq; Michael J Muehlbauer; Christopher B Newgard; Steven Grambow; Michael Freemark
Journal:  J Clin Endocrinol Metab       Date:  2010-10-20       Impact factor: 5.958

9.  Adult subjects with Prader-Willi syndrome show more low-grade systemic inflammation than matched obese subjects.

Authors:  A Caixàs; O Giménez-Palop; M Broch; C Vilardell; A Megía; I Simón; G Giménez-Pérez; D Mauricio; J Vendrell; C Richart; J M González-Clemente
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

10.  Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.

Authors:  Andrea M Haqq; Michael Muehlbauer; Laura P Svetkey; Christopher B Newgard; Jonathan Q Purnell; Steven C Grambow; Michael S Freemark
Journal:  Clin Endocrinol (Oxf)       Date:  2007-07-30       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.